Berger Financial Group’s Gilead Sciences GILD Stock Holding History

Berger Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.57M	Sell	47,146 -14,016	-23%	-$1.96M	0.37%	60
2025 Q4	$7.51M	Sell	61,162 -421	-0.7%	-$51.2K	0.43%	50
2025 Q3	$6.84M	Sell	61,583 -118	-0.2%	-$13.4K	0.41%	55
2025 Q2	$6.84M	Buy	61,701 +415	+0.7%	+$44.2K	0.44%	46
2025 Q1	$6.87M	Buy	+61,286	New	+$6.32M	0.48%	45
2023 Q2	–	Sell	-2,508	Closed	-$208K	–	290
2023 Q1	$208K	Sell	2,508 -69,721	-97%	-$5.77M	0.03%	259
2022 Q4	$6.2M	Buy	72,229 +853	+1%	+$67.5K	0.82%	30
2022 Q3	$4.4M	Buy	71,376 +2,225	+3%	+$140K	0.65%	41
2022 Q2	$4.27M	Buy	69,151 +1,511	+2%	+$93.6K	0.62%	47
2022 Q1	$4.02M	Buy	+67,640	New	+$4.32M	0.51%	60
2021 Q1	–	Sell	-57,942	Closed	-$3.38M	–	211
2020 Q4	$3.38M	Buy	+57,942	New	+$3.5M	0.59%	66

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Berger Financial Group's GILD Position: Q1 2026 in Review

Berger Financial Group reduced its Gilead Sciences (GILD) stake by 23% in Q1 2026, selling an estimated $1.96M and leaving 47,146 shares worth $6.57M. The position accounts for 0.37% of the portfolio, ranked #60.

Berger Financial Group first reported a position in GILD in Q4 2020 and has held it in 11 quarters since. The position peaked at $7.51M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Berger Financial Group held 47,146 shares of Gilead Sciences worth $6.57M as of Q1 2026.
Berger Financial Group sold 14,016 Gilead Sciences shares in Q1 2026, an estimated $1.96M.
Gilead Sciences made up 0.37% of Berger Financial Group's portfolio in Q1 2026, its #60 holding.
Berger Financial Group first reported a position in Gilead Sciences in Q4 2020 and has held it in 11 quarters since.
Berger Financial Group's Gilead Sciences position peaked at $7.51M in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Berger Financial Group's 13F filing for Q1 2026, filed 28 Apr 2026.